Sanofi Licenses OTC Tamiflu From Roche To Attempt First US Flu Treatment Switch

Sanofi consumer health chief Alan Main says with the US the largest OTC drug market, a successful switch for Tamiflu, marketed in the US by Roche subsidiary Genentech, would support the firm's global strategy for expanding cough and cold remedy sales.